Full-Time

Lead Director

Category Manager, Baby Care

Deadline 10/31/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$100k - $231.5k/yr

+ Bonus/commission or short-term incentive + Equity award

Company Historically Provides H1B Sponsorship

Woonsocket, RI, USA

Hybrid

Hybrid work is indicated, with travel of up to approximately 20% based on business needs.

Bachelor's

Category
Operations & Logistics (1)
Required Skills
Microsoft Office
Market Research
Financial analysis
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • At least 10 years of experience in merchandising, category management, consumer packaged goods, or related business leadership roles with full profit-and-loss ownership.
  • Previous experience building, leading, and developing high-performing teams.
  • A proven track record of delivering or exceeding financial targets in a complex, fast-paced environment.
  • Strong understanding of trends, ingredients, and evolving consumer behaviors.
  • Ability to pivot quickly, solve problems in real time, and balance strategy with hands-on execution.
  • Demonstrated analytical, strategic, and storytelling skills, including turning insights into action.
  • A proven track record of influencing others with and without authority.
  • Excellent verbal and written communication skills, very strong interpersonal and presentation skills, and strong executive presence.
  • Expertise leveraging Microsoft Office Suite, including advanced Excel and PowerPoint.
  • Willingness to travel up to approximately 20% based on business needs.
  • A Bachelor's degree or equivalent years of relevant work experience.
Responsibilities
  • Own and deliver the Baby Care category profit-and-loss statement, driving sales, margin, and share growth across the business.
  • Set and execute a forward-looking category strategy and innovation roadmap grounded in customer and market insight.
  • Build and evolve a differentiated, trend-right assortment by identifying white-space opportunities, emerging trends, ingredients, and brands.
  • Lead vendor strategy, foster strong partnerships, and negotiate to unlock joint growth and value creation.
  • Develop and execute integrated promotional and pricing strategies across weekly, seasonal, and annual programs.
  • Partner cross-functionally with Inventory, Pricing, Finance, Store Brands, Store Design, Operations, and Digital to deliver seamless omnichannel execution.
  • Elevate CVS.com as a Baby Care destination through digital merchandising and storytelling.
  • Analyze performance and consumer behavior to continuously optimize assortment, pricing, and promotions.
  • Maintain a strong pulse on the competitive landscape and evolving consumer needs.
  • Lead, coach, and develop a high-performing team while building a strong pipeline of future leaders.
  • Champion inclusive, customer-focused strategies that reflect and serve a diverse customer base.
Desired Qualifications
  • Passion for the Baby Care category and product trends.
  • At least 15 years of category management and/or direct spend experience, with a track record of meeting or exceeding financial objectives and profit-and-loss ownership.
  • Experience developing and executing category and merchandising strategies that drive business growth.
  • At least 15 years of experience influencing others with and without authority.
  • At least 15 years of experience building high-performing teams and developing key talent, with a demonstrated passion for developing new leaders and helping them realize their ability to impact the business.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
  • CVS Caremark settled FTC probes July 14, 2026, reducing legal overhang.
  • CVS expanded Eli Lilly weight-loss access in early fourth quarter 2026.

What critics are saying

  • Louisiana's February 2026 $45 million settlement keeps PBM reform pressure on Caremark margins.
  • Aetna paid $117.7 million on March 11, 2026 for Medicare coding fraud allegations.
  • Federal and state antitrust actions threaten a Caremark-Aetna breakup by 2027.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies across 87 million PBM members.
  • CVS combines retail, insurance, and PBM data under one operating system.
  • CVS launched Google Cloud partnerships and AI tools across claims, service, and engagement.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 28th, 2026
CVS stock down 12% in a month despite 34% annual gain, faces 2027 headwinds

CVS Health stock has declined 12.3% over the past month, sitting about 15% below its 52-week high, though it remains up 34% over the trailing twelve months. The company's revenue reached approximately $415 billion, up 7.4% year-over-year. Management raised its full-year 2026 adjusted earnings per share guidance by $0.60 to a range of $7.90 to $8.10. For 2027, the company anticipates membership declines at Caremark and continued 340B programme pressure, offset by Aetna's recovery, which added over $2 billion in adjusted operating income in the first half of 2026. Management considers a 2027 adjusted EPS outlook of at least $8.44 reasonable. Historically, CVS has experienced varied recovery periods following market downturns, with some rebounds taking years rather than months.

Yahoo Finance
Aug 25th, 2026
CVS and Roche stocks could benefit from expanding GLP-1 drug market

CVS Health and Roche could benefit from the growing GLP-1 drug market, alongside current leaders Eli Lilly and Novo Nordisk. CVS Health has improved its financial performance, with second-quarter revenue rising 7.3% year-over-year to $106.1 billion and adjusted earnings per share increasing 42.5% to $2.58. The pharmacy chain offers all approved GLP-1 medicines in the US, including Eli Lilly's Zepbound and Foundayo, plus Novo Nordisk's Wegovy. CVS also provides low-cost online consultations at $29 to assess patient eligibility for GLP-1 drugs. Beyond GLP-1 initiatives, CVS is addressing previous business challenges and is positioned to capitalise on rising healthcare spending in the US over the next decade.

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.